Our mechanistic investigation revealed that MIR31HG promoted cancer stem cell-related malignant properties of lung cancer cells via H3 histone modification of GLI2 transcriptional activity and its downstream stemness-related molecules. The gene discussed is GLI2; the disease is lung cancer.